arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

CRYO CELL INTERNATIONAL INC

CCEL
$4.05 ▼ -0.16 (-3.80%) at close
Healthcare ·Services-Misc Health & Allied Services, NEC ·USServices-Misc Health & Allied Services, NEC
64 Visible periods
34 Metrics
Peer-ranked Benchmarks
Price Chart
57
Health
Fair
Moderately Bullish
auto_awesome

Analytical Summary

CRYO CELL INTERNATIONAL INC shows strong fundamentals with top-quartile Return on Common Equity (%) and Debt to Equity. Overall, the data suggests a moderately positive outlook with manageable risks.

Market Cap $32.6M
Dividend Yield —
Revenue Growth -1.9% ↗
Op. Margin 15.4% ↗
ROIC -8.5% ↘
FCF / Share $0.23 ↗
Trailing P/E 57.9x
Price / Book —
FCF Yield 5.6%
Debt / Equity -0.47
info Valuation on last close. End-of-day price, Sep 24, 2026.

64-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$7.78M
↓ -1.9% —
Net Income Profit after all expenses
$554.59K
↑ +55.9% —
Operating Margin Operating profit as % of sales
15.4%
↑ +54.6% 32th
FCF / Share Free cash flow per share
$0.23
↑ +210.1% —
Long-Term Debt Long-term obligations
$8.28M
— -0.5% —
trending_up

Bullish Indicators

  • Debt to EquityDebt to Equity is in the top quartile (lower is better)
  • Return on Common Equity (%)Return on Common Equity (%) is in the top quartile
warning

Bearish Risks

  • Profit Margin (%)Profit Margin (%) is in the bottom quartile

Health Breakdown

Profitability ↓
42
Returns ↓
77
Financial Health ↓
75
Cash Quality
6

Dividend History

Dividend / share · sourced from SEC filings
$0.25 Latest / share
-72.2% YoY
-72.2% 2-yr CAGR

bar_chart Data from SEC EDGAR XBRL filings

Synced 2 days ago 17 years · 64 quarters